Pain and Perception: Exploring Psychedelics as Novel Therapeutic Agents in Chronic Pain Management
Current Pain and Headache Reports · 2025-12 · 29 (1)
DOI: 10.1007/s11916-024-01353-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Pain and Headache Reports, online erschienen am 07.01.2025. Verfasst von Natalie H Strand und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pain Medicine, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA. strand.natalie@mayo.edu. Hauptthemen laut MEDLINE: Chronic Pain, Hallucinogens, Pain Management, Pain Perception. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 117 Literaturangaben.
Themen: Schmerzmanagement
Abstract (Originalsprache)
PURPOSE OF REVIEW: Chronic pain affects approximately 1.5 billion people worldwide, representing the leading cause of disability and a significant financial burden on healthcare systems. Conventional treatments, such as opioids and non-steroidal anti-inflammatory drugs, are frequently linked to adverse effects, including dependency and gastrointestinal issues, and often offer limited long-term relief. This review explores the potential of psychedelics, including psilocybin, LSD, and ketamine, as alternative therapeutic agents in chronic pain management. RECENT FINDINGS: These substances modulate pain perception through actions on serotonergic and glutamatergic systems and may promote neuroplasticity, offering novel pathways for pain relief. Specifically, the review details the pharmacologic actions of psychedelics, their effects on chronic pain syndromes such as cancer pain, migraines, and neuropathic pain, and their clinical implications. The safety profiles, patient responses, and analgesic properties of these compounds are examined, highlighting the need for further research to validate their efficacy and optimize their therapeutic use in pain management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pain Medicine, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA. strand.natalie@mayo.edu.
- Mayo Clinic Alix School of Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA.
- Department of Anesthesiology and Perioperative Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA.
- Division of Pain Medicine, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA.
- Department of Anesthesiology, Creighton University School of Medicine, Mountain View Headache and Spine Institute, Phoenix, AZ, USA.
- Mountain View Headache and Spine Institute, Phoenix, AZ, USA.
Zitieren
APA
Strand, N. H., Whitney, M., Johnson, B., Dunn, T., Attanti, S., Maloney, J., Misra, L., Gomez, D., Viswanath, O., Emami, E., & Leathem, J. (2025). Pain and Perception: Exploring Psychedelics as Novel Therapeutic Agents in Chronic Pain Management. Current Pain and Headache Reports, 29(1). https://doi.org/10.1007/s11916-024-01353-0
Vancouver
Strand NH, Whitney M, Johnson B, Dunn T, Attanti S, Maloney J, et al. Pain and Perception: Exploring Psychedelics as Novel Therapeutic Agents in Chronic Pain Management. Current Pain and Headache Reports. 2025;29(1). doi:10.1007/s11916-024-01353-0
BibTeX
@article{Strand2025,
author = {Strand, Natalie H and Whitney, Madeline and Johnson, Brooks and Dunn, Tyler and Attanti, Sumedha and Maloney, Jillian and Misra, Lopa and Gomez, Diego and Viswanath, Omar and Emami, Eric and Leathem, James},
title = {Pain and Perception: Exploring Psychedelics as Novel Therapeutic Agents in Chronic Pain Management},
journal = {Current Pain and Headache Reports},
year = {2025},
volume = {29},
number = {1},
doi = {10.1007/s11916-024-01353-0}
}
EUVIMED